Abstract
A drug that activates glutamate receptors offers promise for a new class of anti-psychotic therapeutics and sheds light on the pathophysiology of this devastating disease (pages 1102-1107).
Original language | English (US) |
---|---|
Pages (from-to) | 1018-1019 |
Number of pages | 2 |
Journal | Nature medicine |
Volume | 13 |
Issue number | 9 |
DOIs | |
State | Published - Sep 2007 |
Externally published | Yes |
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)